Showing results (11-20 of 460) with videos related to
Sort By:
Pageof 46
Current Medical Research and Opinion|November 23, 2007
Effect of pramlintide as an adjunct to basal insulin on markers of cardiovascular risk in patients with type 2 diabetesCarol Wysham, Cameron Lush, Bei Zhang, et al.Diabetes, Obesity & Metabolism|March 3, 2025
A systematic literature review on the burden of diabetic ketoacidosis in type 2 diabetes mellitusCarol Wysham, Anila Bindal, Fleur Levrat-Guillen, et al.Journal of Women'S Health (2002)|December 2, 2022
Determinants of Hormone Replacement Therapy Knowledge and Current Hormone Replacement Therapy UseLaurén A Doamekpor, Sara K Head, Erin South, et al.Diabetes, Obesity & Metabolism|June 7, 2016
Baseline factors associated with glycaemic response to treatment with once-weekly dulaglutide in patients with type 2 diabetesCarol Wysham, Bruno Guerci, David D'Alessio, et al.Journal of Women'S Health (2002)|October 17, 2022
Behaviors Related to Medication Safety and Use During PregnancySara K Head, Laurén Doamekpor, Erin M South, et al.Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association|February 13, 2024
Computed tomography of a canine omental torsion secondary to a chronic abdominal gossypiboma and concurrent incidental broad ligament torsionEmily Ball, Amy Larkin, Germaine HungDiabetes Technology & Therapeutics|March 5, 2025
Continuous Glucose Monitoring-Based Titration of Once-Weekly Insulin Icodec in Insulin-Naive Individuals with Type 2 Diabetes (ONWARDS 9): A Phase 3b, Multicenter, Single-Arm, Treat-to-Target Clinical TrialRichard M Bergenstal, Björg Ásbjörnsdóttir, Tanvir Johanning Bari, et al.Diabetes, Obesity & Metabolism|August 5, 2022
Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspectiveChristophe De Block, Clifford Bailey, Carol Wysham, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 21, 2016
EFFECT OF TOTAL DAILY DOSE ON EFFICACY, DOSING, AND SAFETY OF 2 DOSE TITRATION REGIMENS OF HUMAN REGULAR U500 INSULIN IN SEVERELY INSULIN-RESISTANT PATIENTS WITH TYPE 2 DIABETESCarol Wysham, Robert C Hood, Mark L Warren, et al.Diabetes, Obesity & Metabolism|January 7, 2020
The relationship between HbA1c and hypoglycaemia in patients with diabetes treated with insulin degludec versus insulin glargine 100 units/mLAthena Philis-Tsimikas, Wendy Lane, Ulrik Pedersen-Bjergaard, et al.Pageof 46